Is a personalized pharmacotherapeutic approach closed for acute coronary syndrome?

Expert Opin Pharmacother. 2021 Apr;22(5):527-529. doi: 10.1080/14656566.2021.1877659. Epub 2021 Jan 31.

Authors

Udaya S Tantry¹, Amit Rout^{1

2}, Kevin P Bliden¹, Paul A Gurbel¹

Affiliations

¹ Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Baltimore, MD, USA.
² Division of Cardiology, Einstein Medical Center Philadelphia, Philadelphia, Pennsylvania, USA.

PMID: 33517805
DOI: 10.1080/14656566.2021.1877659

No abstract available

Publication types

Editorial

MeSH terms

Acute Coronary Syndrome* / drug therapy
Humans
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors

Substances

Platelet Aggregation Inhibitors